141 related articles for article (PubMed ID: 8799827)
1. Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent.
Leppä S; Vleminckx K; Van Roy F; Jalkanen M
J Cell Sci; 1996 Jun; 109 ( Pt 6)():1393-403. PubMed ID: 8799827
[TBL] [Abstract][Full Text] [Related]
2. Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells.
Leppä S; Härkönen P; Jalkanen M
Cell Regul; 1991 Jan; 2(1):1-11. PubMed ID: 2007184
[TBL] [Abstract][Full Text] [Related]
3. Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells.
Kato M; Saunders S; Nguyen H; Bernfield M
Mol Biol Cell; 1995 May; 6(5):559-76. PubMed ID: 7545031
[TBL] [Abstract][Full Text] [Related]
4. The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma.
Bayer-Garner IB; Smoller BR
J Cutan Pathol; 2001 Feb; 28(2):83-9. PubMed ID: 11168756
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous loss of expression of syndecan-1 and E-cadherin in the embryonic palate during epithelial-mesenchymal transformation.
Sun D; Mcalmon KR; Davies JA; Bernfield M; Hay ED
Int J Dev Biol; 1998 Jul; 42(5):733-6. PubMed ID: 9712528
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-1 ectodomain regulates matrix-dependent signaling in human breast carcinoma cells.
Burbach BJ; Ji Y; Rapraeger AC
Exp Cell Res; 2004 Oct; 300(1):234-47. PubMed ID: 15383330
[TBL] [Abstract][Full Text] [Related]
7. Translational suppression of syndecan-1 expression in Ha-ras transformed mouse mammary epithelial cells.
Kirjavainen J; Leppä S; Hynes NE; Jalkanen M
Mol Biol Cell; 1993 Aug; 4(8):849-58. PubMed ID: 8241570
[TBL] [Abstract][Full Text] [Related]
8. Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression.
Watanabe A; Mabuchi T; Satoh E; Furuya K; Zhang L; Maeda S; Naganuma H
J Neurooncol; 2006 Mar; 77(1):25-32. PubMed ID: 16132527
[TBL] [Abstract][Full Text] [Related]
9. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype.
Contreras HR; Fabre M; Granés F; Casaroli-Marano R; Rocamora N; Herreros AG; Reina M; Vilaró S
Biochem Biophys Res Commun; 2001 Aug; 286(4):742-51. PubMed ID: 11520060
[TBL] [Abstract][Full Text] [Related]
11. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotype.
Watari J; Saitoh Y; Fujiya M; Shibata N; Tanabe H; Inaba Y; Okamoto K; Maemoto A; Ohta T; Yasuda A; Ayabe T; Ashida T; Yokota K; Obara T; Kohgo Y
J Gastroenterol; 2004; 39(2):104-12. PubMed ID: 15069616
[TBL] [Abstract][Full Text] [Related]
12. Suppression of syndecan-1 expression in endothelial cells by tumor necrosis factor-alpha.
Kainulainen V; Nelimarkka L; Järveläinen H; Laato M; Jalkanen M; Elenius K
J Biol Chem; 1996 Aug; 271(31):18759-66. PubMed ID: 8702532
[TBL] [Abstract][Full Text] [Related]
13. The role of syndecan-1 in malignancies.
Inki P; Jalkanen M
Ann Med; 1996 Feb; 28(1):63-7. PubMed ID: 8932508
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of syndecan-1 expression confer potent serum-dependent growth in human 293T cells.
Numa F; Hirabayashi K; Tsunaga N; Kato H; O'Rourke K; Shao H; Stechmann-Lebakken C; Varani J; Rapraeger A; Dixit VM
Cancer Res; 1995 Oct; 55(20):4676-80. PubMed ID: 7553648
[TBL] [Abstract][Full Text] [Related]
15. Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells.
Leppä S; Mali M; Miettinen HM; Jalkanen M
Proc Natl Acad Sci U S A; 1992 Feb; 89(3):932-6. PubMed ID: 1736308
[TBL] [Abstract][Full Text] [Related]
16. Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence.
Day RM; Hao X; Ilyas M; Daszak P; Talbot IC; Forbes A
Virchows Arch; 1999 Feb; 434(2):121-5. PubMed ID: 10071246
[TBL] [Abstract][Full Text] [Related]
17. The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones.
Munesue S; Kusano Y; Oguri K; Itano N; Yoshitomi Y; Nakanishi H; Yamashina I; Okayama M
Biochem J; 2002 Apr; 363(Pt 2):201-9. PubMed ID: 11931647
[TBL] [Abstract][Full Text] [Related]
18. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
Oncol Rep; 2005 Aug; 14(2):449-57. PubMed ID: 16012729
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of cell surface heparan sulfate proteoglycans in human mammary epithelial cells and lung fibroblasts.
Lories V; Cassiman JJ; Van den Berghe H; David G
J Biol Chem; 1992 Jan; 267(2):1116-22. PubMed ID: 1339431
[TBL] [Abstract][Full Text] [Related]
20. Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice.
Alexander CM; Reichsman F; Hinkes MT; Lincecum J; Becker KA; Cumberledge S; Bernfield M
Nat Genet; 2000 Jul; 25(3):329-32. PubMed ID: 10888884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
